UK bank takes 12.75% stake in Indian outsourcer having originally sold out in 2007.
Category: Deals
Jaguar bites into Sun Cataltix
Tata’s Jaguar Land Rover joins B round for Sun Catalytix.
AOL and O’Reilly back Bit.ly
AOL Ventures participated as a new investor alongside corporate venturing peer O’Reilly AlphaTech Ventures in the B round of Bit.ly.
British Gas lights up AlertMe deal
AlertMe, a UK-based home energy conservation company, has raised £15m ($23.9m) in its third investment round which included a strategic investor and local utility British Gas. British Gas invested £5.7m in cash for its 15.96% stake and will take a seat on AlertMe’s board, it said. Alongside its equity investment, British Gas has agreed to… Continue reading British Gas lights up AlertMe deal
Altaris sells down Creganna-Tactx Medical
A year after AIG sells venture capital operation Altaris the firm realises part of its Creganna-Tactx Medical stake.
Symetis sniffs up venture round
Novartis and Truffle Capital part of consortium in $25.8m C round for Switzerland’s Symetis.
IDev opens $46m cash artery
Undisclosed healthcare company joins venture consortium investing $46m in IDev Technologies.
Mast Kalandar tucks into latest round
Vegetarian fast food chain Mast Kalandar continues adding restaurants with latest round.
BASF warms up with Aspen Aerogels deal
Aspen Aerogels raises more than $110m in aggregate with latest series B round of funding led by Germany-based chemical conglomerate BASF.
Nokia and Cisco find their Netmagic
Nokia Growth Partners and Cisco join mutual fund company Fidelity International in Netmagic Solutions’ $12.5m latest round.
Disney finds Passenger for latest deal
Disney’s Steamboat Ventures joins consortium investing $7.5m in Think Passenger.
Microsoft re-emerges as venture investor
Software group Microsoft has reemerged as a corporate venturing investor by joining AppNexus’ latest round.
Threatmetrix rejects initial CyberSource overtures
CyberSource’s $2bn acquisition by credit card company Visa scuppers initial plans to join Threatmetrix’s investor list.
GSK spins out assets to form Convergence
UK-listed pharmaceutical company GlaxoSmithKline will own 18% of Convergence after asset spin-off.